Article: Altered NAD+ and Glutathione Metabolism in Fatty Liver Disease: Preclinical Findings

PrevNext
Liver Disease Liver Health Preclinical

Altered NAD+ and Glutathione Metabolism in Fatty Liver Disease: Preclinical Findings

Synopsis

In patients with non-alcoholic fatty liver disease (NAFLD), researchers identified altered liver metabolism, specifically increased demand for NAD+ and glutathione (GSH), a key antioxidant. Blood levels of amino acids involved in GSH synthesis (glycine, serine) were lower in those with more liver fat. Liver enzyme analysis confirmed impaired GSH production. Supplementing mice on a Western diet with NAD+ and GSH precursors prevented liver fat accumulation. In a small human study, serine supplementation improved liver function and reduced fat. This suggests restoring NAD+ and GSH metabolism through diet may treat NAFLD.

Journal

Molecular Systems Biology

Share

Read more

Metabolic Health

Nicotinamide Riboside Dose Improves Metabolic Flexibility: Preclinical Findings

SynopsisMetabolic flexibility—the ability to switch between burning carbs and fats—is a marker of metabolic health. To study NR's effect on this, mice on a mildly obese diet received varying NR dos...

Read more
Neurological Health

SARM1 Enzyme Drives Axonal NAD+ Loss and Degeneration: Preclinical Findings

Synopsis Axonal degeneration, or the breakdown of nerve fibers, happens early in many neurological diseases. The protein SARM1 is a key driver of this process, causing axons to lose NAD+, a vital ...

Read more